Skip to main content

Lupus

      Obintuzumab in Lupus Nephritis
      • EurekAlert
      In a post hoc analysis of the phase 2 NOBILITY trial, researchers found that treatment with obinutuzumab—an antibody that targets a protein expressed on certain immune cells—was superior to placebo for preserving kidney function and preventing flares in patients with lupus nephritis, a kidney condition associated with the autoimmune disease lupus.
      ACR QD Clinic - Hemoptysis
      BMJ State of the Art (full read) review of ADVANCES in LUPUS THERAPY (Morand EF, et al).
      - Recent SLE RCTs
      - Pathogenesi

      Dr. John Cush RheumNow

      1 year 11 months ago
      BMJ State of the Art (full read) review of ADVANCES in LUPUS THERAPY (Morand EF, et al). - Recent SLE RCTs - Pathogenesis, genetics, epigenetics - Phenotypes - Emerging treatments - Guidelines on Rx https://t.co/qZFvQkaFeO https://t.co/r9IriOR8FF
      RheumNow Live registration is NOW OPEN! Early bird pricing through 11/30/2023. Register today!

      https://t.co/1SjBiM7Daj

      Dr. John Cush RheumNow

      1 year 11 months ago
      RheumNow Live registration is NOW OPEN! Early bird pricing through 11/30/2023. Register today! https://t.co/1SjBiM7Daj https://t.co/w2cFcj85r5
      Anti-Phospholipid Antibodies - Infrequent in Certain Groups

      Among patients with SLE, high titers of anti-phospholipid

      Dr. John Cush RheumNow

      1 year 11 months ago
      Anti-Phospholipid Antibodies - Infrequent in Certain Groups Among patients with SLE, high titers of anti-phospholipid (aPL) antibodies were most prevalent in whites and Latinos and less so for Black and Asian individuals, researchers found. https://t.co/qQygcS3Ktw https://t.co/FVKlvFuuFn
      2023 EULAR Lupus Management Recommendations

      EULAR has published updated recommendations for the management of systemic

      Dr. John Cush RheumNow

      1 year 11 months ago
      2023 EULAR Lupus Management Recommendations EULAR has published updated recommendations for the management of systemic lupus erythematosus (SLE) based on new evidence and expert opinion - formulationg five overarching principles and 13 recommendations. https://t.co/9PKvsEUTM3 https://t.co/gElp6tyEQZ
      Dr. Jack Cush reviews RheumNow's top entries the PMR Campaign, news, journal reports and regulatory actions. #PMR Polymyalgia rheumatica is very common, yet there is little research on the Dx & Management of PMR by #PCPs! Mayo study prevalence 701 per 100,000 (women=870 and men =508 per 100,000 population). https://t.co/7JZFeRPRnn
      Among patients with systemic lupus erythematosus (SLE), high titers of anti-phospholipid (aPL) antibodies were most prevalent in whites and Latinos and less so for Black and Asian individuals, researchers found.
      2023 EULAR Lupus Management Recommendations

      EULAR has published updated recommendations for the management of systemic

      Dr. John Cush RheumNow

      1 year 11 months ago
      2023 EULAR Lupus Management Recommendations EULAR has published updated recommendations for the management of systemic lupus erythematosus (SLE) based on new evidence and expert opinion - formulationg five overarching principles and 13 recommendations. https://t.co/Fzh8F33u3U https://t.co/2baAVsm8Bo
      Dr. Jack Cush discusses the news, journal articles and regulatory actions. This week we discuss JAKne, DLE and SLE and more.
      ×